[1]Garg RK,Jain A, Malhotra HS,et al. Drug-resistant tuberculous meningitis. Expert Rev Anti Infect Ther,2013,11(6):605-621.[2]Kontos F, Maniati M, Costopoulos C,et al. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study. J Microbiol Methods, 2004,56(2):291-294.[3]Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.Tuber Lung Dis,1998,79(1):3-29.[4]刘佳文,吕红艳,吴雪琼. 16S rRNA基因序列在分枝杆菌分类鉴定的研究进展. 国外医学临床生物化学与检验学分册, 2001,22(5):265-266.[5]Marais S, Thwaites G, Schoeman JF,et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010,10(11): 803-812.[6]中国防痨协会基础专业委员会.结核病诊断实验室检验规程.北京:中国教育文化出版社,2006:54,56-57.[7]Parish T, Stoker NG.Mycobacteria protocols.Totowa:Humana Press, 1998.[8]World Health Organization. Policy guidance on drug-susceptibility testing(DOS) of second-line antituberculosis drugs. WHO/HTM/TB/2008.392. Geneva:World Health Organization,2008.[9]Pang Y, Zhou Y, Zhao B, et al. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One, 2012,7(3):e32976.[10]Duong DA, Nguyen TH, Nguyen TN,et al. Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluroquinolone resistance in Vietnam. Antimicrob Agents Chemother,2009,53(11):4835-4839.[11]王婷,赵雁林,刘家云,等.结核性脑膜炎临床分离株基因型和耐药表型的特征分析.中国防痨杂志,2013, 35(9):656-663.[12]Li WM, Wang SM, Li CY,et al. Molecular epidemiology of Mycobacterium tuberculosis in China: a nationwide random survey in 2000. Int J Tuberc Lung Dis,2005,9(12):1314-1319.[13]Jou R, Chiang CY, Huang WL. Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan. J Clin Microbiol, 2005, 43(1):95-100.[14]Marais BJ, Victor TC, Hesseling AC, et al.Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J Clin Microbiol,2006,44(10):3539-3543.[15]Jarlier V, Nikaido H. Permeability barrier to hydrophilic so-lutes in Mycobacterium chelonei. J Bacteriol,1990,172(3):1418-1423.[16]Rodríguez JC, Cebrián L, López M,et al. Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis. J Antimicrob Chemother,2004,53(3):441-444.[17]HeymB, Alzari PM, Honoré N,et al. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol,1995,15(2):235-245.[18]Kapur V, Li LL, Hamrick MR,et al. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med,1995, 119(2): 131-138.[19]Takiff HE, Salazar L, Guerrero C, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother,1994,38(4):773-780.[20]Maus CE,Plikaytis BB,Shinnick TM. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother,2005,49(8):3192-3197.[21]Nair J, Rouse DA, Bai GH,et al. The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis. Mol Microbiol, 1993, 10(3):521-527.[22]Okamoto S, Tamaru A, Nakajima C, et al. Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. Mol Microbiol,2007,63(4):1096-1106. |